Nova Via Detox Center
Equity stake in a clinical detox and addiction treatment operator addressing one of the most under-supplied segments of the U.S. behavioral health market.
A private investment platform deploying capital across real estate, private credit, life sciences, and operating companies. Built on asymmetric conviction, structural discipline, and the long game.
Bryson Hunter is the founder and principal of Bryson Hunter Enterprises, a privately held investment platform overseeing a multi-vertical portfolio that spans real estate development, structured private credit, behavioral health, life sciences, and consumer ventures.
A former collegiate athlete turned operator-investor, his approach is shaped by high-performance discipline and a transactional mindset honed through years of principal investing, deal structuring, and operational leadership in opportunity zones, private equity, and asset acquisition.
Today, he leads capital deployment, partnership formation, and strategic direction across eight active holdings — building enduring value through deliberate concentration, not diffusion.
Each holding is selected for asymmetric upside, structural defensibility, and operator alignment. Capital is deployed with conviction; outcomes are measured in years, not quarters.
Equity stake in a clinical detox and addiction treatment operator addressing one of the most under-supplied segments of the U.S. behavioral health market.
Active capital partner across multiple ground-up and value-add real estate projects, structured through equity, preferred positions, and secured debt instruments.
Strategic capital position in a Las Vegas-based consumer and lifestyle venture targeting the high-traffic Nevada market.
A specialized portfolio of land transfer fee rights — perpetual, recurring, inflation-linked cash flow rights attached to land tracts across multiple jurisdictions.
A privately held diversified entity used as a capital vehicle for select co-investment positions, structured ownership, and long-duration asset positions.
A vertically integrated research compound distribution platform serving the U.S. research market, with proprietary protocol systems and a 60+ SKU active catalog.
The platform's structured lending arm — originating secured promissory notes, bridge facilities, and asset-backed credit instruments at a minimum 50% annualized return threshold.
A capital vehicle deploying into operator-led growth opportunities, real assets, and select strategic positions sourced through the broader network.
Capital allocation, deal selection, and partnership formation are filtered through a simple, non-negotiable framework.
Every deal is underwritten to deliver outsized upside relative to downside. A minimum 50% annualized return threshold is the floor — not the ceiling. Concentration is preferred to diversification when conviction is earned.
Capital follows operators, not pitch decks. Partnership selection prioritizes proven execution, transactional integrity, and aligned incentives. Investments are structured with downside protections — but staffed with people who don't need them.
Time horizon is the most underused asset class. Positions are structured to compound across multi-year cycles, with patience as a deliberate competitive advantage against shorter-horizon capital.
The platform partners with a small, selective group of capital allocators and operators. Inbound interest is reviewed personally.
For accredited investors, family offices, and capital allocators seeking direct access to a curated set of private holdings, structured credit positions, and real-asset opportunities.
For operators, founders, and deal sponsors with active mandates requiring growth capital, structured credit, or strategic partnership. We back people first, deals second.
The information contained on this website is provided by Bryson Hunter Enterprises (together with its affiliated entities, "BHE," "we," "our," or "us") for general informational purposes only. By accessing or using this website, you acknowledge and agree to the terms, limitations, and disclaimers set forth below. If you do not agree, please discontinue use of this website.
Bryson Hunter Enterprises operates as a privately held investment platform overseeing capital deployed by Bryson Hunter and affiliated principals across a curated portfolio of operating companies, real estate projects, private credit positions, and related holdings. BHE and its affiliated entities (including but not limited to Bryson Hunter Real Estate LLC, Black River Investments LLC, Sunpeak Investments, Freehold Holdings, 7071 Holdings LLC, and Axis Chems LLC) are private companies.
Neither BHE nor any of its affiliates is registered as a broker-dealer, investment adviser, commodity pool operator, commodity trading advisor, or in any similar capacity with the United States Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), the Commodity Futures Trading Commission (CFTC), or any state or foreign securities, banking, or financial regulatory authority. Nothing on this website should be construed as an offer to provide such services.
Nothing contained on this website constitutes an offer to sell, or a solicitation of an offer to buy, any security, partnership interest, membership interest, debt instrument, or other investment product. All investment opportunities referenced on this website are private and offered exclusively pursuant to applicable exemptions from registration under the Securities Act of 1933, as amended (the "Securities Act"), and applicable state securities laws, including without limitation Rule 506 of Regulation D and, where applicable, Regulation S.
Any actual offer or sale of securities will be made only by means of a definitive private placement memorandum, subscription agreement, operating agreement, loan agreement, promissory note, and/or such other transaction documents as BHE or the applicable issuer may deliver to a prospective investor. Prospective investors should rely solely on the information contained in those definitive offering documents — not on the contents of this website — when making any investment decision.
No federal or state securities regulator has approved or disapproved any offering, passed upon the merits of any investment, or confirmed the accuracy or adequacy of any disclosure. Any representation to the contrary is a criminal offense.
Participation in any investment opportunity offered or referenced by BHE is limited to persons who qualify as "accredited investors" as defined under Rule 501 of Regulation D promulgated under the Securities Act, and, where applicable, "qualified purchasers" as defined under Section 2(a)(51) of the Investment Company Act of 1940.
Where any offering relies on Rule 506(c) of Regulation D, BHE or its agents will take reasonable steps to verify each prospective investor's accredited investor status prior to accepting any subscription. Verification may require third-party confirmation by a licensed attorney, certified public accountant, registered broker-dealer, or registered investment adviser, or such other documentation as BHE deems sufficient in its sole discretion.
Prospective investors who are not accredited should not submit inquiries, capital commitments, or subscription requests through this website.
This website contains forward-looking statements, including but not limited to statements regarding investment strategy, target returns (such as the minimum 50% annualized return threshold referenced for the private credit platform), expected deal structures, sector outlook, and future portfolio composition. Forward-looking statements are based on current assumptions, expectations, and information and are subject to numerous risks, uncertainties, and changes in circumstances.
Targeted, projected, or anticipated returns are aspirational and are not guaranteed. Actual results may differ materially — and may be negative — from those expressed or implied. No representation or warranty is made that any targeted return will be achieved, that the strategies described will be successful, or that any investor will receive a return of capital. BHE undertakes no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date such statement was made.
References to the platform's assets under management ("AUM"), portfolio composition, number of active holdings, transaction history, or prior investment outcomes are provided for informational purposes only and represent a point-in-time snapshot. AUM figures may include committed but undeployed capital, real estate at estimated market value, equity stakes at internal valuation, and debt instruments at principal outstanding, and are subject to change without notice.
Past performance is not indicative of, and does not guarantee, future results. Prior investments referenced on this website were made under specific market, regulatory, and operational conditions that may no longer exist. No investor should infer that future opportunities will perform similarly to prior opportunities.
Investments in private companies, real estate projects, private credit instruments, and related opportunities are speculative, illiquid, and involve a high degree of risk, including the risk of total loss of principal. Such investments are suitable only for sophisticated, accredited investors who can afford to bear the economic risk of an investment for an indefinite period of time and who have no need for liquidity with respect to the capital committed. Material risks include, without limitation:
Illiquidity — Interests are not publicly traded, there is no secondary market, and transfer is typically restricted by contract and securities laws; investors should expect to hold their position for the full investment horizon, which may be five years, ten years, or longer. Concentration — The platform may hold concentrated positions in a limited number of holdings, sectors, or geographies, increasing exposure to idiosyncratic risk. Leverage — Certain holdings may employ debt financing, which amplifies both potential returns and potential losses. Valuation — Private holdings are valued internally and are not subject to daily mark-to-market; reported valuations may not reflect realizable value. Operational and execution risk — Outcomes depend significantly on the performance of operating partners, sponsors, borrowers, and counterparties, any of whom may underperform or default. Regulatory risk — Changes in tax law, securities regulation, zoning, licensing, or industry-specific rules may adversely affect any holding.
Nothing contained on this website constitutes investment, legal, tax, accounting, regulatory, or other professional advice. The information presented does not take into account the particular investment objectives, financial situation, tax position, or needs of any specific person. Each prospective investor should consult with their own independent legal, tax, financial, and investment advisors before making any investment decision.
The platform's real estate holdings, including without limitation positions associated with Bryson Hunter Real Estate LLC, Midtown Development Group LLC, and related development and value-add projects, are subject to material risks specific to real property and real estate development, including but not limited to: market and cyclical risks affecting property values, rents, and absorption; entitlement, zoning, and permitting risk; construction cost overruns and schedule delays; environmental and title risks; tenant credit and vacancy risk; financing and refinancing risk; interest rate risk; natural disaster and casualty risk; and risks specific to joint venture partners, sponsors, and counterparties.
Real estate co-investment, preferred equity, and secured debt positions held by the platform are typically illiquid, subject to project-specific business plans, and carry no guarantee of return or principal protection.
Activities conducted through Black River Investments LLC and related lending vehicles involve the origination of secured promissory notes, bridge facilities, and asset-backed credit instruments. These instruments are subject to material risks including, without limitation: borrower default; insufficiency of collateral; delay or impairment of foreclosure, UCC enforcement, or other remedies; subordination to senior creditors; bankruptcy-related stays and impairments; and concentration in specific borrowers, sectors, or geographies.
Stated minimum return thresholds (including the minimum 50% annualized return threshold) reflect underwriting targets — not guarantees of outcome. Loans may default, be modified, be extended, or be settled at a loss.
Holdings associated with Freehold Holdings consist of contractual rights attached to underlying land tracts. Such rights are subject to risks specific to private transfer fee instruments, including without limitation: enforceability under applicable state law (which varies significantly by jurisdiction and continues to evolve); the creditworthiness and cooperation of underlying property owners, title insurers, and closing agents; recording and chain-of-title risks; legal challenges to the instrument; and changes in federal or state regulation affecting private transfer fee arrangements.
The platform's holdings in healthcare and life sciences companies — including but not limited to its equity position in Nova Via Detox Center — are operating company investments and are subject to material risks specific to the healthcare sector, including: regulatory and licensing risk at the federal, state, and local levels; accreditation risk; payor reimbursement and rate-setting risk; staffing and clinical operations risk; malpractice and patient-safety liability; HIPAA and privacy compliance risk; and significant exposure to evolving behavioral health and addiction treatment regulation.
Nothing on this website constitutes medical advice, a recommendation of any treatment, or any endorsement of any specific clinical service. Healthcare-related holdings are passive equity investments by BHE and are operated independently by their respective management teams.
Axis Chems LLC is a research compound distribution platform that supplies materials strictly for laboratory and in-vitro research use only. Products distributed by Axis Chems are not approved by the United States Food and Drug Administration (FDA) for diagnostic or therapeutic use in humans or animals, are not dietary supplements, are not cosmetics, and are not intended for human or veterinary consumption.
All Axis Chems customers are required to be qualified research professionals operating in compliance with all applicable federal, state, and local laws and regulations. Customers bear sole responsibility for the lawful use, handling, storage, and disposal of any materials purchased. Nothing on this website constitutes a medical or therapeutic claim, a recommendation for use, or an endorsement of any product for any purpose other than bona fide laboratory research.
BHE holds Axis Chems as an equity investment. Inquiries regarding Axis Chems products, catalog, or regulatory positioning should be directed to Axis Chems directly and are not handled through this website.
Bryson Hunter and affiliated principals may serve in multiple capacities across the platform — including, without limitation, as principal investor, lender, borrower, guarantor, manager, board member, advisor, or operator — with respect to the same or related holdings. Material conflicts of interest may arise, including but not limited to: principals investing on terms different from those offered to outside investors; allocation of investment opportunities among affiliated entities; related-party transactions among portfolio companies; and concurrent service to multiple holdings with competing interests.
BHE seeks to address such conflicts on a case-by-case basis in accordance with applicable governing documents, fiduciary obligations (where applicable), and customary commercial practice. Specific conflict disclosures are provided in the definitive offering documents associated with each opportunity.
Information shared by BHE in connection with any inquiry, application, due diligence process, or offering — whether transmitted via this website, email, telephone, in person, or otherwise — is confidential and proprietary. Recipients may not reproduce, distribute, publish, or otherwise share such information without the prior written consent of BHE. By submitting an inquiry or application through this website, you agree to maintain the confidentiality of any non-public information subsequently provided to you.
This website and any opportunities referenced herein are directed solely to U.S. persons (as defined under Regulation S of the Securities Act) located within the United States. Nothing on this website constitutes an offer to sell or a solicitation of an offer to buy any security or interest in any jurisdiction in which such offer or solicitation would be unlawful. Persons accessing this website from jurisdictions outside the United States are responsible for compliance with all applicable local laws.
BHE reserves the absolute right, in its sole discretion, to decline any inquiry, application, capital commitment, or subscription from any prospective investor, operator, sponsor, or counterparty, for any reason or no reason. Acceptance into any opportunity is subject to satisfactory completion of background, KYC (know-your-customer), AML (anti-money-laundering), sanctions, accredited investor verification, suitability, and such other diligence as BHE deems appropriate.
Information submitted through inquiry or application forms on this website (including name, contact information, capital range, and accompanying narrative) is collected and used solely for the purpose of evaluating the inquiry and contacting the submitter. Such information is not sold to third parties. BHE may retain submitted information in accordance with applicable record-keeping obligations. Submitters who wish to have their information deleted may contact us at the email address below.
References on this website to third-party operating companies, sponsors, projects, or counterparties are made solely to describe the nature of BHE's portfolio activities and do not constitute an endorsement, joint marketing arrangement, or representation that any such third party endorses BHE. All third-party names, logos, and trademarks remain the property of their respective owners.
Information on this website is provided "as is" and "as available," without warranty of any kind, express or implied. While BHE endeavors to maintain accurate and current information, no representation or warranty is made as to the accuracy, completeness, or timeliness of any content. Information may be updated, modified, or removed at any time without notice. Prospective investors should not rely on any information contained on this website in making any investment decision and should instead rely solely on the definitive offering documents provided to them.
To the maximum extent permitted by applicable law, neither BHE nor any of its affiliates, officers, employees, agents, or representatives shall be liable for any direct, indirect, incidental, consequential, special, or punitive damages of any kind arising out of or in connection with the use of, or inability to use, this website or any information contained herein, including without limitation any decision made or action taken in reliance on such information.
All inquiries reviewed directly by principal. Response within 72 hours.